Equities Research Analysts’ New Coverage for October 5th (AVBC, CAMP, HESAY, KRSA, LMRI, ONDS, ORIC, SMBC, TAM, VYLR)

Equities Research Analysts’ new coverage for Monday, October 5th:

Hovde Group began coverage on shares of Avidia Bancorp (NYSE:AVBC). They issued an outperform rating and a $26.00 price target on the stock.

Oppenheimer Holdings, Inc. initiated coverage on shares of CAMP4 Therapeutics (NASDAQ:CAMP). They issued an outperform rating and a $15.00 target price on the stock.

The Goldman Sachs Group, Inc. initiated coverage on shares of Hermes International (OTCMKTS:HESAY). The Goldman Sachs Group, Inc. issued a sell rating on the stock.

Wedbush began coverage on shares of Cyclerion Therapeutics (NASDAQ:KRSA). The firm issued an outperform rating and a $44.00 target price on the stock.

Truist Financial Corporation assumed coverage on shares of Lumexa Imaging (NASDAQ:LMRI). Truist Financial Corporation issued a buy rating and a $18.00 target price on the stock.

Citizens Jmp assumed coverage on shares of Ondas (NASDAQ:ONDS). The firm issued a market outperform rating and a $14.00 target price on the stock.

Leerink Partners started coverage on shares of Oric Pharmaceuticals (NASDAQ:ORIC). They issued an outperform rating and a $26.00 price target on the stock.

Hovde Group started coverage on shares of Southern Missouri Bancorp (NASDAQ:SMBC). They issued a market perform rating and a $76.00 target price on the stock.

Berenberg Bank began coverage on shares of Tatton Asset Management (LON:TAM). They issued a buy rating and a GBX 820 target price on the stock.

Bank of America Corporation initiated coverage on shares of Vylor (NYSE:VYLR). The firm issued a buy rating and a $78.00 target price on the stock.

Leerink Partners began coverage on shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL). Leerink Partners issued an outperform rating and a $8.00 target price on the stock.